Miriam Kidron - Apr 17, 2023 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Chief Scientific Officer, Director
Signature
/s/ Miriam Kidron
Stock symbol
ORMP
Transactions as of
Apr 17, 2023
Transactions value $
$0
Form type
4
Date filed
4/20/2023, 06:00 AM
Previous filing
Mar 15, 2023
Next filing
May 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +213K +105.62% 415K Apr 17, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 17,750 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.